Skip to main content
Premium Trial:

Request an Annual Quote

Timothy Kish, Christian Henry, Trevor Hawkins, Edward Barnholt, Jim Golden

Premium

Timothy Kish has resigned from his post as chief financial officer at Illumina, the company said during its first quarter conference call last week.

Kish, who will remain as a consultant to the San Diego life sciences company, will be replaced by Christian Henry, formerly CFO of Tickets.com. Henry previously served as vice president of finance and corporate controller at Affymetrix as well as chief accounting officer and corporate controller at Inhale Therapeutic Systems.


Trevor Hawkins has been appointed chief science and technology officer of MDS, the company announced last week.

Hawkins most recently served as president of molecular diagnostics at GE Healthcare as well as senior vice president of development at Amersham Biosciences. Hawkins holds a BS and PhD in biochemistry from the University of Sussex.


Edward Barnholt has been named to the board of directors of eBay, the online auctioneer said last week. Barnholt stepped down as chief executive officer of Agilent Technologies in March.


Jim Golden has left his position as vice president of research at IDC's market research unit Life Science Insights to join SAIC as chief technology officer for its commercial life science group. Golden told BioInform, Pharmacogenomics Reporter's sister publication, that he will be responsible for adapting technologies that SAIC has developed for its government and public-sector clients to the pharmaceutical IT market.


XDx has appointed Vikram Jog as the company's CFO. Jog most recently served as vice president of finance for Celera Genomics and Celera Diagnostics. Prior that position, Jog served as vice president of planning and corporate controller for Applera Corporation.

Filed under

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.